Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02257151 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate the Safety, Pharmacokinetics and Target Engagement of BMS-986142 in Healthy Subjects
A Phase 1 study of Healthy Adult, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 118
- Enrollment target
- 1
- Study location
NCT02257151: Completed Phase 1 study of Healthy Adult, sponsored by Bristol-Myers Squibb.
NCT02257151 is a Phase 1 study of Healthy Adult that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 118 participants, above the 59-participant average among 8 other Healthy Adult trials with a reported enrollment target (100% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02257151, a Phase 1 study of Healthy Adult, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 118 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the safety, pharmacokinetics, and target engagement of BMS-986142 in healthy subjects.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG BMS-986142
Study Locations (1)
California
- Wcct Global, Llc - Cypress
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-08 |
| Phase | Phase 1 |
What the finished NCT02257151 record still lists
NCT02257151 is an interventional study that assigns participants to a tested intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, above the 59-participant average among 8 other Healthy Adult trials with a reported enrollment target (100% higher).
The record links to 1 condition, with Healthy Adult appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02257151 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02257151 about?
NCT02257151 is a clinical study titled "Study to Evaluate the Safety, Pharmacokinetics and Target Engagement of BMS-986142 in Healthy Subjects". The purpose of this study is to evaluate the safety, pharmacokinetics, and target engagement of BMS-986142 in healthy subjects.
What is the current status of trial NCT02257151?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 118 participants. The study started on 2014-09. Estimated completion is 2015-08.
What conditions does trial NCT02257151 study?
This clinical trial studies the following conditions: Healthy Adult.
What interventions are being tested in trial NCT02257151?
The interventions under investigation include: Placebo (DRUG), BMS-986142 (DRUG).
Who is sponsoring clinical trial NCT02257151?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02257151 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02257151's enrollment target sits among peer trials
118 2nd of 8 the highest of 8 other Healthy Adult trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Adult trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Skin Irritation and Sensitization of SILURCLOUD Fibrous Collagen Matrix
RECRUITING · NA
-
Avocado and Postprandial Responses
RECRUITING · NA
-
Skin Prick Test to Evaluate Immunogenic Response of SILURCLOUD™ Fibrous Collagen Matrix in Healthy Volunteers
RECRUITING · NA
-
Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations
RECRUITING · NA
-
Nicotinamide Adenine Dinucleotide Responses to a Nutritional Supplement
RECRUITING · NA
-
Molecular Indicators of Systematic Fitness
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia